Home
>
National Drug Code (NDC)
>
Famciclovir
Famciclovir - 0054-0196-13 - (Famciclovir)
Drug Information of Famciclovir
| Product NDC: | 0054-0196 |
| Proprietary Name: | Famciclovir |
| Non Proprietary Name: | Famciclovir |
| Active Ingredient(s): | 125 mg/1 & nbsp; Famciclovir |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Famciclovir
| Product NDC: | 0054-0196 |
| Labeler Name: | Roxane Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090128 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110103 |
Package Information of Famciclovir
| Package NDC: | 0054-0196-13 |
| Package Description: | 30 TABLET in 1 BOTTLE (0054-0196-13) |
NDC Information of Famciclovir
| NDC Code | 0054-0196-13 |
| Proprietary Name | Famciclovir |
| Package Description | 30 TABLET in 1 BOTTLE (0054-0196-13) |
| Product NDC | 0054-0196 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Famciclovir |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110103 |
| Marketing Category Name | ANDA |
| Labeler Name | Roxane Laboratories, Inc. |
| Substance Name | FAMCICLOVIR |
| Strength Number | 125 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
